Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non‐insulin‐dependent diabetes mellitus patients with hypertension-Reference-Cited by-同舟云学术

Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non‐insulin‐dependent diabetes mellitus patients with hypertension

Published:1998-08 Issue:2 Volume:244 Page:95-107
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:Journal of Internal Medicine

Author:

Östman ¹,Asplund ²,Bystedt ³,Dahlöf ⁴,Jern ⁴,Kjellström ⁵,Lithell ⁶,

Affiliation:

1. From the Centre of Metabolism and Endocrinology, Huddinge University Hospital, Karolinska Institute, Stockholm, the

2. Department of Internal Medicine, Regional Hospital, Umeå, the

3. Department of Endocrinology and Diabetology, Karolinska Hospital, Stockholm, the

4. Clinical Experimental Research Laboratory, Department of Medicine, SU/Östra University Hospital, Gothenburg, the

5. Department of Internal Medicine, Helsingborg Hospital, Helsingborg and the

6. Department of Geriatrics, University Hospital, Uppsala, Sweden

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2796.1998.00319.x

Reference57 articles.

1. Diabetes and cardiovascular disease. The Framingham study

2. Diabetes and atherosclerosis: An epidemiologic view

3. Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

4. Drug Treatment of Hypertension in Patients With Diabetes Mellitus

5. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension;Cochrane Database of Systematic Reviews;2018-11-14

2. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24

3. First-line renin–angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus;Journal of Human Hypertension;2018-05-01

4. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension;Cochrane Database of Systematic Reviews;2015-01-11